相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis
Prerana Williamson et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)
Tumor Necrosis Factor Alpha-308G/A Gene Polymorphisms Combined with Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio Predicts the Efficacy and Safety of Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis Arthritis
Ziran Wang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism
Ziran Wang et al.
THROMBOSIS JOURNAL (2022)
Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways
Xingnan Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma
Seo-Hee Kim et al.
Clinical and Molecular Allergy (2021)
The relevance of CYSLTR1 gene polymorphism to the severity of allergic rhinitis and clinical responsiveness of montelukast in children
Miaomiao Zhao et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)
The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease
Monika Katko et al.
JOURNAL OF INFLAMMATION RESEARCH (2021)
Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization
Yifan Wu et al.
IMMUNITY (2021)
The-675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population
B. U. Anaya-Macias et al.
AUTOIMMUNITY (2020)
Advances and novel developments in mechanisms of allergic inflammation
Xiaorui Han et al.
ALLERGY (2020)
Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility A meta-analysis
Xin Zhang et al.
MEDICINE (2020)
Correlation Between PAI-1 Gene 4G/5G Polymorphism and the Risk of Thrombosis in Ph Chromosome-Negative Myeloproliferative Neoplasms
Xueya Zhang et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2020)
A PEAR1 polymorphism (rs12041331) is associated with risk of coronary artery aneurysm in Kawasaki disease
Lei Pi et al.
ANNALS OF HUMAN GENETICS (2019)
Promoter Polymorphism (-308G/A) of Tumor Necrosis Factor-Alpha (TNF-α) Gene and Asthma Risk: An Updated Meta-Analysis
Sang Wook Kang et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2019)
Asthma pharmacotherapy: an update on leukotriene treatments
Hoang Kim Tu Trinh et al.
EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)
Recent Advances in Clinical Allergy and Immunology 2019
Dagmar Simon
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2019)
THE ROLE OF PAI-1 GENE 4G/5G POLYMORPHISM AND DIAGNOSTIC VALUE OF BIOMARKERS IN ALLERGIC AND NON-ALLERGIC ASTHMA PHENOTYPE
Marina Lampalo et al.
ACTA CLINICA CROATICA (2018)
Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma
Marina Lampalo et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2017)
Genetics of allergy and allergic sensitization: common variants, rare mutations
Klaus Bonnelykke et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
A Human Platelet Receptor Protein Microarray Identifies the High Affinity Immunoglobulin E Receptor Subunit (FcεR1) as an Activating Platelet Endothelium Aggregation Receptor 1 (PEAR1) Ligand
Yi Sun et al.
MOLECULAR & CELLULAR PROTEOMICS (2015)
The Association of GSDMB and ORMOL3 Gene Polymorphisms With Asthma: A Meta-Analysis
Chun-Ni Zhao et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2015)
Genome-wide association studies of atopic dermatitis
Mayumi Tamari et al.
JOURNAL OF DERMATOLOGY (2014)
The-675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis
Wei Nie et al.
PLOS ONE (2012)
Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis
Ozlem Yilmaz Ozbek et al.
ALLERGY AND ASTHMA PROCEEDINGS (2009)
Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation
Z. Ma et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Binding of upstream stimulatory factor 1 to the E-Box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells
Zhongcai Ma et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma
Miriam F. Moffatt et al.
NATURE (2007)
Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility
N. Hizawa et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis
Jian Zhang et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2006)
Structure and function of the platelet integrin αIIbβ3
JS Bennett
JOURNAL OF CLINICAL INVESTIGATION (2005)
Diagnosis of allergy syndromes: do symptoms always mean allergy?
PA Eigenmann
ALLERGY (2005)
Glycoprotein IIIa P1A1/A2 polymorphism and sudden cardiac death
J Mikkelsson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)